National Heart, Lung, and Blood Institute Workshop: improving outcomes for pulmonary vascular disease

MeSH terms

• Adult
• Age Factors
• Biomarkers
• Cardiovascular Agents / therapeutic use
• Child
• Clinical Trials as Topic / methods
• Clinical Trials as Topic / standards
• Forecasting
• Humans
• Hypertension, Pulmonary / classification
• Hypertension, Pulmonary / etiology
• Hypertension, Pulmonary / mortality
• Hypertension, Pulmonary / physiopathology
• Hypertension, Pulmonary / therapy*
• National Heart, Lung, and Blood Institute (U.S.)*
• Phenotype
• Prognosis
• Research
• United States
• Vascular Resistance